Protective effectiveness of previous SARS-CoV-2 infection an

All estimates of protection waned within months against reinfection but remained high
and sustained for hospital admission or severe disease. Individuals with hybrid immunity
had the highest magnitude and durability of protection, and as a result might be able
to extend the period before booster vaccinations are needed compared to individuals
who have never been infected.

Related Keywords

Qatar , Canada , Canadian , Embase Ovid , Solidarity Response Fund , Melinda Gates Foundation , Coalition For Epidemic Preparedness Innovations , Forecasting Team , Asian Development Bank , Pfizer , Canadian Medical Association Joule Innovation Fund , Immunity Task , Public Health Agency Of Canada , Robert Koch Institute , Melinda Gates Foundation Strategic Investment Fund , Health Canada , Health Emergencies Program , Cochrane Central Register , Controlled Trials , Europe Pubmed Central , Bias In Non Randomized Studies , Response Fund , Epidemic Preparedness , Healthy Longev , Englj Med , Core Collection , Infect Dis , Epidemic Preparedness Innovations , Emergencies Program , Public Health Agency , Task Force , Canadian Medical Association Joule Innovation , Melinda Gates , Royal Trustee , Flagship Pioneering , Alethea Medical ,